Home

The Provincial Directorate of Public Health in Holguín today highlighted the need to strengthen the control measures of COVID-19 after the report here of 63 positive cases on Monday, one the highest figure in a day in the eastern territory since the start of the pandemic in Cuba in March 2020.

The Phase II clinical trials of Soberana Plus in convalescents of COVID 19 will include 450 people and will broaden the inclusion criteria compared to Phase I, informed today an expert from the Finlay Vaccine Institute (IFV), the entity that developed this vaccine candidate against COVID-19.

Solidarity organizations and Cuban residents in European countries carry out a campaign to send a container to Cuba with supplies intended to support immunization against Covid-19, said Reynaldo Romero, project coordinator today.